SIGN 129: Antithrombotics: indications and management

 

Download the guideline

[arrow] Full guideline [Acrobat logo] (1.60MB)
[arrow] Quick Reference Guide [Acrobat logo] (847K)
arrow Apple app apple badge small
arrow Android app android badge small
[arrow] Information about Acrobat files

[Guideline cover]SIGN 129: June 2013 update

This update (June 2013) provides a new recommendation for the use of novel oral anticoagulant medication in patients with atrial fibrillation who are at risk of stroke. The full guideline provides recommendations based on current evidence for best practice in the management of adult patients on antithrombotic therapy

Guideline No 129
ISBN 978 1 905813 91 9
August 2012, updated June 2013

Supporting material

[arrow] Prevention of stroke in patients with atrial fibrillation: A guide for primary care [Acrobat logo] (426K)
[arrow] Register of interests [Acrobat logo] (32K)
[arrow] Copyright Request form [Acrobat logo] (145K)
[arrow] Search narrative
[Acrobat logo] (88K)
[arrow]

SIGN Guideline Survey

[Acrobat logo] (139K)

 

Related guidelines

[arrow] SIGN 93: Acute coronary syndromes
[Acrobat logo]
[arrow] SIGN 94: Cardiac arrhythmias in coronary heart disease
[Acrobat logo]
[arrow] SIGN 95: Man. of chronic heart failure
[Acrobat logo]
[arrow] SIGN 96: Man. of stable angina
[Acrobat logo]
[arrow] SIGN 97: Risk estimation and the prevention of cardiovascular disease
[Acrobat logo]
[arrow] SIGN 108 Management of patients with stroke or TIA: assessment... [Acrobat logo]
[arrow] SIGN 111: Management of hip fracture in older people
[Acrobat logo]
[arrow] SIGN 118: Management of patients with stroke: rehabilitation... [Acrobat logo]
[arrow] SIGN 122: Prevention and man. of venous thromboembolism
[Acrobat logo]

 

patient information

Share with a colleague